UNIVA Oak Holdings Limited
3113・Standard Market・Securities & Commodity Futures
Business
UNIVA・Oak Holdings, Inc. operates under the slogan "value co-creation company," with five core segments: the Renewable Energy business (planning and sale of solar power generation equipment), the Beauty & Healthcare business (planning and sale of beauty and health-related products), the Trading business (EC wholesale of Hong Kong-made Chinese herbal medicine and health-related products for the Chinese market), the Growth Support business (M&A advisory and corporate finance), and the Digital Marketing business (provision of marketing support tools), alongside Media, Shared Services, and Sports businesses. The group comprises 12 consolidated subsidiaries and 4 equity-method affiliates, and is listed on the Standard Market of the Tokyo Stock Exchange. The company traces its roots to a textile manufacturer founded in 1868, and changed to its current name in 2023.
Business Model
As a holding company, it allocates management resources (the three capitals of Human, Knowledge, and Financial) to each operating company, advocating a philosophy of "Co-creative Capitalism" that generates synergies among businesses. Revenue is composed of sales and installation contracting of solar power generation equipment, direct-to-consumer sales of beauty and health products, wholesale sales of items such as traditional Chinese medicine to Chinese e-commerce platforms, M&A brokerage and equity finance fees, and subscriptions for digital marketing tools. Working capital is funded through own funds as well as borrowings from financial institutions and affiliated companies and bond issuance.
Company Strengths
Consolidated subsidiary UNIVA Securities holds a Type I Financial Instruments Business license, enabling it to provide M&A intermediary services, corporate finance, and equity finance in an integrated manner. In FY2026 (ending March 2026), the company completed the EXIT of one equity finance deal, and in June 2026 it formed and began operating its first fund, among other initiatives that indicate it is beginning to function as a fundraising mechanism both within and outside the group.
UNIVA Hong Kong Trading Limited obtained a wholesale license for traditional Chinese medicine from the Hong Kong Special Administrative Region government, and began wholesale sales to Tmall, JD.com, and Alibaba Health. In its first year (FY2026, ending March 2026), the company recorded net sales of ¥570 million and operating profit of ¥7 million, establishing a sales channel into the Chinese market—a unique entry barrier not found in other segments.
"Kikikomi," a tool developed by UNIVA Gyro-n Inc. that automatically generates review and word-of-mouth text from survey responses, obtained a patent in November 2025. In addition to being combined with the company's existing EFO (Entry Form Optimization) service, the company has also newly rolled out an ad operation service, "Gyro-n AdOPS." The number of new contracts in FY2026 (ending March 2026) progressed largely as planned. Intellectual property protection through the patent supports differentiation from competitors.
ENVALITH's Perspective
Performance Trend
Revenue peaked at ¥5,036 million in FY2024 (ended March 2024) before declining sharply for two consecutive fiscal years, falling to ¥2,331 million (down 19.1% year on year) in FY2026 (ending March 2026). The decline was mainly driven by downturns in the Renewable Energy Business (down 42.1% year on year) and the Beauty & Healthcare Business (down 59.2% year on year). On the other hand, the newly launched Trading business recorded ¥570 million, providing support. Operating loss narrowed to ¥687 million (from ¥722 million in the prior period), and ordinary loss improved significantly to ¥549 million (from ¥986 million in the prior period). As an external factor, foreign exchange gains of ¥224 million resulting from the continued depreciation of the yen contributed significantly to the improvement in ordinary income/loss. Net loss attributable to owners of the parent improved to ¥582 million (from ¥740 million in the prior period), but the cumulative loss over the past five fiscal years has reached ¥5,103 million.
Growth Strategy
Aiming for a return to profitability through rapid expansion of the Trading business and "expansion and enlargement" of operations through M&A
On April 1, 2026, the company acquired 51% of the shares of UNIVA Marketing Limited (Cayman) (acquisition cost of ¥895 million). By incorporating the supply and sales system provision to Naturally Plus brand product sales outlets across 8 countries worldwide, the company expects Trading business net sales of ¥4,423 million (up 676% year-on-year) for FY2027 (ending March 2027).
UNIVA Energy is focusing on high-voltage solar power generation facilities, grid-connected storage batteries, and vertical bifacial solar power generation facilities. While the vertical type facilities are being completed successively in Hokkaido, the high-voltage and storage battery segments have not yet secured orders during FY2026 (ended March 2026). Net sales of ¥1,349 million (up 97.8% year-on-year) are forecast for FY2027 (ending March 2027).
The company is building an ecosystem centered on "UNIVA FUND," which began formation in March 2026, establishing a business model that both provides income and capital gains to investors and offers growth capital and management support to companies. Through strengthened collaboration with M&A intermediary and IFA networks, net sales of ¥173 million and operating profit of ¥42 million are forecast for FY2027 (ending March 2027).
In April 2026, the company launched "WATERLESS BOUNCY ESSENCE LOTION," promoting a shift from a single-product brand to a full-line brand. Under new management, the company aims to recover new member acquisition through organizational reform and continued strengthening of marketing activities. Net sales of ¥520 million (up 9.8% year-on-year) and an operating loss of ¥124 million are forecast for FY2027 (ending March 2027).
At the ordinary general meeting of shareholders scheduled to be held on June 25, 2026, proposals will be submitted for a reduction of capital stock by ¥447 million (from ¥547 million to ¥100 million) and appropriation of surplus (transfer of other capital surplus of ¥601 million to retained earnings). The company plans to fully eliminate the retained earnings deficit of ¥601 million as of March 31, 2026, thereby establishing a framework that enables the resumption of dividend payments.
Last updated: July 19, 2026

